“Recognition of New Antimicrobial Targets with Novel Benzaaldehyde containing O-alkyl chains”

Authors

  • Vikram sinha, Triloki Prasad, Harendar kumar Nivatya, Nitin kumar, Satendra kumar, Sachin kumar yadav, Sanjay verma, Satakshi singh, Gunjan Sharma

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.124

Abstract

There is an essential need to develop novel antibacterial agents against new bacterial targets in order to avoid the problem of cross-resistance. Almost in every bacterium topoisomerase IA is present, so that the enzyme activity is available to resolve topological blocks involving DNA single strands. It is a reasonable route to look for novel antibiotics by trying to develop small molecules that can trap the covalent complex formed by bacterial type IA topoisomerases. Bacterial topoisomerase is a target for development of novel antimicrobials because it has an important role in the transcription events. Thus topoisomerases are the potent drug targets due to their bactericidal effect.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

“Recognition of New Antimicrobial Targets with Novel Benzaaldehyde containing O-alkyl chains”. (2022). Journal of Pharmaceutical Negative Results, 1064-1075. https://doi.org/10.47750/pnr.2022.13.S10.124